H.B. Fuller Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga

03-27

H.B. Fuller Company (NYSE:FUL) will release its first-quarter financial results, after the closing bell, on Wednesday, March 26.

Analysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at 50 cents per share, down from 67 cents per share in the year-ago period. H.B. Fuller projects quarterly revenue of $769.11 million, compared to $810.42 million a year earlier, according to data from Benzinga Pro.

On Jan. 15, H.B. Fuller posted weaker-than-expected fourth-quarter earnings.

H.B. Fuller shares fell 1.1% to close at $53.83 on Tuesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

Seaport Global analyst Michael Harrison downgraded the stock from Buy to Neutral on March 5, 2025. This analyst has an accuracy rate of 67%.
Deutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $75 to $72 on Jan. 22, 2025. This analyst has an accuracy rate of 73%.
JP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and slashed the price target from $70 to $60 on Jan. 17, 2025. This analyst has an accuracy rate of 67%.

Considering buying FUL stock? Here’s what analysts think:

Read This Next:

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2522822783"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522822783\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2522822783?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-27 00:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522822783","market":"hk","top_or_hot":-1,"title":"H.B. Fuller Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call","media":"Benzinga","content":"<html><body><p><strong>H.B. Fuller Company</strong> (NYSE:FUL) will release its first-quarter financial results, after the closing bell, on Wednesday, March 26.</p>\n<p>Analysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at 50 cents per share, down from 67 cents per share in the year-ago period. H.B. Fuller projects quarterly revenue of $769.11 million, compared to $810.42 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On Jan. 15, H.B. Fuller posted weaker-than-expected fourth-quarter earnings.</p>\n<p>H.B. Fuller shares fell 1.1% to close at $53.83 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Seaport Global analyst Michael Harrison downgraded the stock from Buy to Neutral on March 5, 2025. This analyst has an accuracy rate of 67%.</li>\n<li>Deutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $75 to $72 on Jan. 22, 2025. This analyst has an accuracy rate of 73%.</li>\n<li>JP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and slashed the price target from $70 to $60 on Jan. 17, 2025. This analyst has an accuracy rate of 67%.</li>\n</ul>\n<p>Considering buying FUL stock? Here’s what analysts think: </p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</strong></li>\n</ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>H.B. Fuller Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nH.B. Fuller Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2025-03-27 00:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>H.B. Fuller Company</strong> (NYSE:FUL) will release its first-quarter financial results, after the closing bell, on Wednesday, March 26.</p>\n<p>Analysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at 50 cents per share, down from 67 cents per share in the year-ago period. H.B. Fuller projects quarterly revenue of $769.11 million, compared to $810.42 million a year earlier, according to data from Benzinga Pro.</p>\n<p>On Jan. 15, H.B. Fuller posted weaker-than-expected fourth-quarter earnings.</p>\n<p>H.B. Fuller shares fell 1.1% to close at $53.83 on Tuesday.</p>\n<p>Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.</p>\n<p>Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.</p>\n<ul>\n<li>Seaport Global analyst Michael Harrison downgraded the stock from Buy to Neutral on March 5, 2025. This analyst has an accuracy rate of 67%.</li>\n<li>Deutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $75 to $72 on Jan. 22, 2025. This analyst has an accuracy rate of 73%.</li>\n<li>JP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and slashed the price target from $70 to $60 on Jan. 17, 2025. This analyst has an accuracy rate of 67%.</li>\n</ul>\n<p>Considering buying FUL stock? Here’s what analysts think: </p>\n<p><strong>Read This Next:</strong></p>\n<ul>\n<li><strong> Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</strong></li>\n</ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FUL","symbol_name":"富乐","start_time":0,"source_url":"https://www.benzinga.com/25/03/44497901/hb-fuller-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call","article_id":"2522822783","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522822783","pubTimestamp":1743005777,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"FUL":"富乐"},"translate_title":"H.B.更丰厚的收益即将到来；这些最准确的分析师在收益看涨期权之前修改了预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FUL":1},"content_text":"H.B. Fuller Company (NYSE:FUL) will release its first-quarter financial results, after the closing bell, on Wednesday, March 26.\nAnalysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at 50 cents per share, down from 67 cents per share in the year-ago period. H.B. Fuller projects quarterly revenue of $769.11 million, compared to $810.42 million a year earlier, according to data from Benzinga Pro.\nOn Jan. 15, H.B. Fuller posted weaker-than-expected fourth-quarter earnings.\nH.B. Fuller shares fell 1.1% to close at $53.83 on Tuesday.\nBenzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.\nLet's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.\n\nSeaport Global analyst Michael Harrison downgraded the stock from Buy to Neutral on March 5, 2025. This analyst has an accuracy rate of 67%.\nDeutsche Bank analyst David Begleiter maintained a Buy rating and cut the price target from $75 to $72 on Jan. 22, 2025. This analyst has an accuracy rate of 73%.\nJP Morgan analyst Jeffrey Zekauskas maintained an Underweight rating and slashed the price target from $70 to $60 on Jan. 17, 2025. This analyst has an accuracy rate of 67%.\n\nConsidering buying FUL stock? Here’s what analysts think: \nRead This Next:\n\n Top 2 Health Care Stocks That Are Ticking Portfolio Bombs","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}